Orchestra BioMed (NASDAQ:OBIO) Given New $12.00 Price Target at HC Wainwright
Orchestra BioMed (NASDAQ:OBIO – Get Free Report) had its price objective decreased by analysts at HC Wainwright from $14.00 to $12.00 in a research note issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price objective suggests a potential upside of 334.78% from the company’s current price. Several […]
Orchestra BioMed (NASDAQ:OBIO – Get Free Report) had its price objective decreased by analysts at HC Wainwright from $14.00 to $12.00 in a research note issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price objective suggests a potential upside of 334.78% from the company’s current price. Several […]
